MYFEMBREE ®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy

Conditions:   Pregnancy Related;   Pregnancy Complications;   Pregnancy, High Risk Intervention:   Drug: Relugolix + Estradiol + Norethindrone Acetate Sponsor:   Myovant Sciences GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials